[Regulatory] 503A vs 503B in one paragraph, because everyone conflates them
Right, the 503A question again, but with numbers this time.
I have 11 data points over 18 weeks. The pattern is consistent enough that I do not think it is chance, and boring enough that nobody is going to screenshot it, which is usually a good sign.
The thing I would flag for anyone new: the effect I am describing showed up at week 3, not week 52. People give up long before the interesting part.
Interested in whether this matches other people's logs or whether I am an outlier.
best — the order this archive was captured in
API source questions are on-topic and compounders dodging them is newsworthy
Disagree. What you are describing is consistent with 503A, not with what you concluded.
telehealth costs compounding plus compounding markup, total varies
Strongly agree. API source transparency matters.
no pharmacy referral codes, naming is fine, recruiting is not
state board rules differ, say which state
Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.
Asked 17 compounders about API source. One told me, one dodged, one said they cannot say. The answer is the signal.
- 1API source questions are on-topic and compounders dodging them is newsworthy6 comments in this branch · started by u/formulary_fighter